Propanc Biopharma Statistics
NASDAQ: PPCBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.4987+0.0074 (+1.51%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 0.4815 -3.45%
Propanc Biopharma by the numbers
Propanc Biopharma has a market capitalization of $4.9 million based on 9.83M shares outstanding. With trailing EPS of $-17.62, Propanc Biopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 47.5% below its 50-day average and 85.7% below its 200-day average.
Average daily trading volume is 1.79M shares, or about $893,894 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PPCB valuation vs. peer median
| Metric | PPCB | Peer median | Difference |
|---|---|---|---|
| Market cap | $4.90M | $5.06M | -3% |
| Avg. volume | 1.79M | 131.00K | +1268% |
Peer median across 8 companies: XTLB, NCNA, LNAI, XBIO, PULM, RDHL, ADXN, DRMA.
Valuation
- Market cap
- $4.90M
- EPS (TTM)
- $-17.62
- Shares outstanding
- 9.83M
Price and trading
- Previous close
- 0.4913
- Open
- 0.49
- Day range
- 0.46 – 0.5071
- 52-week range
- 0.46 – 48.75
- 50-day moving average
- 0.9507
- Beta
- —
- Volume
- 860.44K
- Average volume
- 1.79M
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 4.90M
- Eps
- -17.62
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 48.75
- Week52 Low
- 0.46
- Avg Volume
- 1.79M
- Shares Outstanding
- 9.83M
- Ma50
- 0.95
- Ma200
- 3.49
- Pct From52w High
- -98.98%
- Pct From52w Low
- 8.41%